700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Research Article Open Access
Mycobacterium tuberculosis is infectious bacteria and causes tuberculosis in humans. M. tuberculosis infects the immune deficient human and shows the symptoms of the infection. Also bacteria stay in latent phase inside the human body and can be active in suitable conditions. One third of the total population of the world is infected by M. tuberculosis; therefore it is very important to have potential drugs against tuberculosis. Mycobacteria have reported multidrug resistance to the available drugs for tuberculosis. Hence, there is a need to find a new target for the drugs. Fatty acid synthase II (FAS II) is the enzyme that catalyzes the synthesis of fatty acid and is not found in humans. It is a multifunctional polypeptide, composed of different domains in which can be targeted individually to inhibit the function of FAS II. 2-Nitropropane Dioxygenase is a part of enoyl reductase domain in FAS II and can be potentially targeted. In this study, the homology modeling of 2NPD from M. tuberculosis has been done and small molecules that have the potential to bind and inhibit the function of the enzyme have been identified. Also the stability of proteinligand complex was determined.
Mycobacterium tuberculosis, Fatty acid synthase II, 2-Nitropropane dioxygenase, Drug design, Homology modeling, Molecular docking, QSAR, MD simulation